Tags

Type your tag names separated by a space and hit enter

[High prevalence of secondary hyperparathyroidism due to vitamin D insufficiency in Graves' disease].
Clin Calcium. 2005 Sep; 15 Suppl 1:68-70; discussion 70.CC

Abstract

We studied concentrations of serum calcium, intact parathyroid hormone (iPTH), and 25 hydroxyvitamin D (25 [OH] D) in 343 patients with Graves' disease (273 women, 70 men) during one year period. The serum 25 (OH) D levels were 37+/-19 nmol/L and vitamin D deficiency (defined as a serum 25 (OH) D value below 25 nmol/L) was found in 35% of the patients. There was a significant seasonal variation in the 25 (OH) D concentrations, with high values of 51+/-21 nmol/L during the summer term (July-September), and with low values of 26+/-17 nmol/L during the winter term (January-March). The average serum iPTH level was 48+/-26 pg/mL, with 26% (89/343) having values above the normal range. Our results showed high prevalence of secondary hyperparathyroidism in patients with Graves' disease during antithyroid drug therapy and vitamin D and/or calcium supplements are recommended for patients with vitamin D deficiency.

Authors+Show Affiliations

Noguchi Thyroid Clinic and Foundation.No affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

jpn

PubMed ID

16272633

Citation

Doi, Yasuko, et al. "[High Prevalence of Secondary Hyperparathyroidism Due to Vitamin D Insufficiency in Graves' Disease]." Clinical Calcium, vol. 15 Suppl 1, 2005, pp. 68-70; discussion 70.
Doi Y, Yamashita H, Noguchi S. [High prevalence of secondary hyperparathyroidism due to vitamin D insufficiency in Graves' disease]. Clin Calcium. 2005;15 Suppl 1:68-70; discussion 70.
Doi, Y., Yamashita, H., & Noguchi, S. (2005). [High prevalence of secondary hyperparathyroidism due to vitamin D insufficiency in Graves' disease]. Clinical Calcium, 15 Suppl 1, 68-70; discussion 70.
Doi Y, Yamashita H, Noguchi S. [High Prevalence of Secondary Hyperparathyroidism Due to Vitamin D Insufficiency in Graves' Disease]. Clin Calcium. 2005;15 Suppl 1:68-70; discussion 70. PubMed PMID: 16272633.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [High prevalence of secondary hyperparathyroidism due to vitamin D insufficiency in Graves' disease]. AU - Doi,Yasuko, AU - Yamashita,Hiroyuki, AU - Noguchi,Shiro, PY - 2005/11/8/pubmed PY - 2006/1/25/medline PY - 2005/11/8/entrez SP - 68-70; discussion 70 JF - Clinical calcium JO - Clin Calcium VL - 15 Suppl 1 N2 - We studied concentrations of serum calcium, intact parathyroid hormone (iPTH), and 25 hydroxyvitamin D (25 [OH] D) in 343 patients with Graves' disease (273 women, 70 men) during one year period. The serum 25 (OH) D levels were 37+/-19 nmol/L and vitamin D deficiency (defined as a serum 25 (OH) D value below 25 nmol/L) was found in 35% of the patients. There was a significant seasonal variation in the 25 (OH) D concentrations, with high values of 51+/-21 nmol/L during the summer term (July-September), and with low values of 26+/-17 nmol/L during the winter term (January-March). The average serum iPTH level was 48+/-26 pg/mL, with 26% (89/343) having values above the normal range. Our results showed high prevalence of secondary hyperparathyroidism in patients with Graves' disease during antithyroid drug therapy and vitamin D and/or calcium supplements are recommended for patients with vitamin D deficiency. SN - 0917-5857 UR - https://www.unboundmedicine.com/medline/citation/16272633/[High_prevalence_of_secondary_hyperparathyroidism_due_to_vitamin_D_insufficiency_in_Graves'_disease]_ L2 - http://www.diseaseinfosearch.org/result/3178 DB - PRIME DP - Unbound Medicine ER -